FDA Panel Vote On Unapproved Peptides Sparks Concerns Over Prescribing Surge
6d
Developing
7
An FDA advisory panel voted on Friday, July 24, 2026, in Washington, D.C., to broaden access to four unapproved peptides, a move experts warn could spark a rapid surge in prescribing. New York Times
